Early Predictive Response to Multi-Tyrosine Kinase Inhibitors in Advanced Refractory Radioactive-Iodine Differentiated Thyroid Cancer: A New Challenge for [18F] …
C Ferrari, G Santo, R Ruta, V Lavelli, D Rubini… - Diagnostics, 2021 - mdpi.com
Differentiated thyroid cancer (DTC) represents the most common thyroid cancer histotype.
Generally, it exhibits a good prognosis after conventional treatments; nevertheless, about …
Generally, it exhibits a good prognosis after conventional treatments; nevertheless, about …
Current Advances in Radioactive Iodine Refractory Differentiated Thyroid Cancer
Background: Differentiated thyroid cancer (DTC) patients have an outstanding overall long-
term survival rate, certain subsets of DTC patients have a very high likelihood of disease …
term survival rate, certain subsets of DTC patients have a very high likelihood of disease …
Impact of 18F-FDG PET/CT on clinical management of suspected radio-iodine refractory differentiated thyroid cancer (RAI-R-DTC)
E Lodi Rizzini, A Repaci, E Tabacchi, L Zanoni… - Diagnostics, 2021 - mdpi.com
Background: As reported in the literature,[18F]-fluorodeoxyglucose positron emission
tomography/computed tomography ([18F]-FDG PET/CT) provides useful qualitative and semi …
tomography/computed tomography ([18F]-FDG PET/CT) provides useful qualitative and semi …
2-[18F]FDG PET in the Management of Radioiodine Refractory Differentiated Thyroid Cancer in the Era of Thyrosin-Kinases Inhibitors: A Real-Life Retrospective …
S Gay, S Raffa, A De'Luca di Pietralata, M Bauckneht… - Diagnostics, 2022 - mdpi.com
Purpose To evaluate the role of 2-[18F] FDGPET/CT in the follow-up of radioiodine refractory
thyroid cancer (RR-TC). Methods Forty-six 2-[18F] FDGPET/CT scans from 14 RR-TC …
thyroid cancer (RR-TC). Methods Forty-six 2-[18F] FDGPET/CT scans from 14 RR-TC …
Scoring system and a simple nomogram for predicting radioiodine refractory differentiated thyroid cancer: a retrospective study
Y Liu, Y Wang, W Zhang - EJNMMI research, 2022 - Springer
Background Differentiated thyroid carcinoma (DTC) originates from abnormal follicular cells
and accounts for approximately 90–95% of thyroid malignancies. The diagnosis of …
and accounts for approximately 90–95% of thyroid malignancies. The diagnosis of …
Multikinase inhibitors for the treatment of asymptomatic radioactive iodine-refractory differentiated thyroid cancer: global noninterventional study (RIFTOS MKI)
MS Brose, JWA Smit, CC Lin, M Tori, DW Bowles… - Thyroid, 2022 - liebertpub.com
Background: Sorafenib and lenvatinib are multikinase inhibitors (MKIs) approved for patients
with radioactive iodine-refractory (RAI-R) differentiated thyroid cancer (DTC). There is no …
with radioactive iodine-refractory (RAI-R) differentiated thyroid cancer (DTC). There is no …
[18F]FDG PET/CT can trigger relevant oncological management changes leading to favorable outcome in iodine-negative thyroid cancer patients
Y Zhi, T Higuchi, S Hackenberg, R Hagen, M Stöth… - Endocrine, 2024 - Springer
Background In patients with iodine-negative thyroid cancer (TC), current guidelines endorse
an [18F] FDG PET/CT to identify dedifferentiated sites of disease. We aimed to determine the …
an [18F] FDG PET/CT to identify dedifferentiated sites of disease. We aimed to determine the …
[HTML][HTML] New approaches for patients with advanced radioiodine-refractory thyroid cancer
The cumulative evidence over the past decades has shown that the incidence of
differentiated thyroid carcinoma (DTC) has exponentially increased. Approximately 10% of …
differentiated thyroid carcinoma (DTC) has exponentially increased. Approximately 10% of …
Can 18F-fluorodeoxyglucose positron emission tomography predict the response to radioactive iodine therapy in metastatic differentiated thyroid carcinoma?
Background 131 I radioactive iodine therapy (RAI) has been commonly applied for
metastatic differentiated thyroid cancer (DTC) and played an adjunctive role to total …
metastatic differentiated thyroid cancer (DTC) and played an adjunctive role to total …
[PDF][PDF] Predictive factor analysis and scoring system for radioiodine-refractory differentiated thyroid cancer: a retrospective study.
Y Liu, Y Wang, W Zhang - 2022 - scholar.archive.org
Background The incidence of thyroid cancer has been rising worldwide. Differentiated
thyroid carcinoma (DTC) originates from abnormal follicular cells and accounts for about 90 …
thyroid carcinoma (DTC) originates from abnormal follicular cells and accounts for about 90 …